IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 1 filers reported holding IKENA ONCOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,315,065 | -31.8% | 534,657 | +3.3% | 0.01% | -26.3% |
| Q2 2023 | $3,395,213 | +86.0% | 517,563 | -2.2% | 0.02% | +58.3% |
| Q1 2023 | $1,825,050 | +29.7% | 529,000 | 0.0% | 0.01% | +71.4% |
| Q4 2022 | $1,407,140 | -25.1% | 529,000 | 0.0% | 0.01% | -36.4% |
| Q3 2022 | $1,878,000 | -19.8% | 529,000 | 0.0% | 0.01% | -69.4% |
| Q2 2022 | $2,343,000 | – | 529,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $5,982,667 | 2.02% |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $13,348,353 | 1.61% |
| CHI Advisors LLC | 1,637,372 | $4,355,409 | 1.16% |
| BVF INC/IL | 2,503,071 | $6,658,169 | 0.28% |
| Artal Group S.A. | 1,549,513 | $4,122 | 0.23% |
| Orbimed Advisors | 2,933,941 | $7,804,283 | 0.15% |
| DAFNA Capital Management LLC | 122,517 | $325,895 | 0.09% |
| Oasis Management Co Ltd. | 140,000 | $372,400 | 0.07% |
| Verition Fund Management LLC | 1,580,375 | $4,203,798 | 0.07% |
| CORNERCAP INVESTMENT COUNSEL INC | 29,465 | $78,377 | 0.01% |